Faculty

Institution

Unit

Venue

Victor Levin

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

The University of Texas MD Anderson Cancer Center

NoneVictor Levin is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Victor Levin

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

brain tumor research neuro-oncology oncology gliomas neurology radiation oncology pharmacology cancer treatment cancer research medicine tumor biology neurosurgery radiation therapy pharmacotherapy neuropathology cancer biology medicinal research surgical oncology anti-cancer agents oncogenes radiation neuroradiology therapeutic targets cancer care clinical neurosurgery radiopharmaceutical therapy molecular cancer vascular biology brain lesion clinical radiation oncology radiation biology tumor innervation cancer imaging cancer genetics cancer cells pharmacological research in vitro toxicology phase ii study cancer management pharmacokinetics pediatric neurosurgery cancer genomics glioblastoma multiforme cerebral blood flow cerebrospinal fluid neurointerventional surgery metronomic chemotherapy malignant disease malignant gliomas tumor targeting tumoral pathology anaplastic gliomas novel therapies clinical neurology neurotology tumor suppressors brain pathology interdisciplinary neurosurgery phase ii trial recurrent malignant gliomas brain tumors prognostic evaluation cancer risk clinical pharmacology spinal oncology prognosis tumor heterogeneity prognostic factors primary brain tumors anaplastic astrocytoma recurrent glioblastoma hypothalamic gliomas glioma patients antitumor activity recurrent medulloblastoma recurrent gliomas

Notable Scholarly Works

Notable Federal Grants

Collaborators

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma. Journal of Clinical Oncology (2025)

medicineoncologyneuro-oncologybrain tumor researchradiation oncologyphase iiiopen-label studygliomasrecurrent grade 3

Ltbk-01. Phase 3 Stellar Study Shows Eflornithine Improves Overall Survival (Os) and Progression Free Survival (Pfs) in Patients With Recurrent 2021 Who Astrocytoma, Idh-Mutant Grade 3. Neuro-Oncology (2024)

Howard ColmanGiuseppe LombardiEric WongTobias WalbertMarica EoliAndrew LassmanDavid PeereboomSani KizilbashCarlos Kamiya-MatsuokaMarshall PitzRoy StrowdAnnick DesjardinsPriya KumthekarWarren MasonAlessia PellerinoRicardo SoffiettiNicholas ButowskiPeter ForsythMohamed HamzaPeter HauEnrico LallanaBurt NaborsDavid PiccioniErik UhlmannLiam WelshPatrick WenJorg DietrichVictor Levin

progression free survivalstellar studyneuro-oncology

Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: From Digital “Flipbooks” to Control Systems Theory. Neurotherapeutics (2022)

Benjamin M EllingsonVictor A LevinTimothy F Cloughesy

medical imagingdrug combinationsearly-phase brain trialsbrain imagingmagnetic resonance imagingneuroradiologyneuroscienceneuro-oncologygliomasradiomicsoncologybrain tumor researchcomplex tumor typesbiomedical imagingradiographic imagingcancer imagingneuroimagingradiation oncologyradiologyexperimental medicinetherapeutic imaging

Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome. Frontiers in Oncology (2020)

Brij S. KarmurJustine PhilteosAram AbbasianBrad E. ZachariaNir LipsmanVictor LevinStuart GrossmanAlireza Mansouri

neurologyoncologyneuro-oncologyblood-brain barrier disruption

Effect of Eflornithine on Mutation Frequency in Temozolomide-Treated U87Mg Cells. Oncotarget (2020)

mutagenesisdrug resistancemutation frequencymolecular biologycell biologymutagenesis (molecular biology technique)

Phase I/II Study of Sorafenib in Combination With Erlotinib for Recurrent Glioblastoma as Part of a 3-Arm Sequential Accrual Clinical Trial: Nabtc 05-02. Neuro-Oncology Advances (2020)

Huanwen ChenJohn KuhnKathleen R LambornLauren E AbreyLisa M DeAngelisFrank LiebermanH Ian RobinsSusan M ChangW K Alfred YungJan DrappatzMinesh P MehtaVictor A LevinKenneth AldapeJanet E DanceyJohn J WrightMichael D PradosTimothy F CloughesyPatrick Y WenMark R Gilbert

pharmacologyneurologyclinical trialscancer treatmentmedicineoncologyneuro-oncologybrain tumor researchrecurrent glioblastomagliomas

Actr-41. an Argument That More Adjuvant Temozolomide Therapy is Better for Glioma Patients. Neuro-Oncology (2019)

pharmacologyneurologycancer treatmentoncologyneuro-oncologybrain tumor researchpharmacotherapyanti-cancer agentsgliomascancer care

How Far Will the Voyager ® Take Us?. CNS Oncology (2019)

space researchastrophysicsdeep space explorationspace scienceastronomydeep space probespace explorationacta astronautica

Clinical Importance of Eflornithine (α-Difluoromethylornithine) for the Treatment of Malignant Gliomas. CNS Oncology (2018)

pharmacologypathologycancer treatmentcancer researchoncologyneuro-oncologybrain tumor researchcancer letterclinical radiation oncologyanti-cancer agentsclinical importancegliomastherapeutic targetsmalignant gliomas

Drug Discovery in Neuro-Oncology: Challenges in the Path Forward. Neuro-Oncology (2018)

pharmacological researchpharmacologyrational drug designdrug discoverydrug targetsdrug repositioningneurosciencebrain tumor researchcancer discoveryneuropsychopharmacologygliomasneuropharmacologytherapeutic targets

1
2
3
4
5
31
10 / page

Victor Levin

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

The University of Texas MD Anderson Cancer Center

NoneVictor Levin is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Victor Levin

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma. Journal of Clinical Oncology (2025)

medicineoncologyneuro-oncologybrain tumor researchradiation oncologyphase iiiopen-label studygliomasrecurrent grade 3

progression free survivalstellar studyneuro-oncology

Benjamin M EllingsonVictor A LevinTimothy F Cloughesy

Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome. Frontiers in Oncology (2020)

Brij S. KarmurJustine PhilteosAram AbbasianBrad E. ZachariaNir LipsmanVictor LevinStuart GrossmanAlireza Mansouri

neurologyoncologyneuro-oncologyblood-brain barrier disruption

Effect of Eflornithine on Mutation Frequency in Temozolomide-Treated U87Mg Cells. Oncotarget (2020)

mutagenesisdrug resistancemutation frequencymolecular biologycell biologymutagenesis (molecular biology technique)

Phase I/II Study of Sorafenib in Combination With Erlotinib for Recurrent Glioblastoma as Part of a 3-Arm Sequential Accrual Clinical Trial: Nabtc 05-02. Neuro-Oncology Advances (2020)

pharmacologyneurologyclinical trialscancer treatmentmedicineoncologyneuro-oncologybrain tumor researchrecurrent glioblastomagliomas

Actr-41. an Argument That More Adjuvant Temozolomide Therapy is Better for Glioma Patients. Neuro-Oncology (2019)

pharmacologyneurologycancer treatmentoncologyneuro-oncologybrain tumor researchpharmacotherapyanti-cancer agentsgliomascancer care

How Far Will the Voyager ® Take Us?. CNS Oncology (2019)

space researchastrophysicsdeep space explorationspace scienceastronomydeep space probespace explorationacta astronautica

Clinical Importance of Eflornithine (α-Difluoromethylornithine) for the Treatment of Malignant Gliomas. CNS Oncology (2018)

Drug Discovery in Neuro-Oncology: Challenges in the Path Forward. Neuro-Oncology (2018)

1
2
3
4
5
31
10 / page